ADUS Addus HomeCare Corp

Nasdaq Services-Home Health Care Services DE CIK: 0001468328
AI RATING
BUY
80% Confidence

Investment Thesis

Addus demonstrates robust fundamental strength with 23.2% YoY revenue growth and exceptional free cash flow generation (13.9% FCF margin), supported by a fortress balance sheet (0.08x D/E). However, weak returns on equity (2.2%) and assets (1.7%) indicate capital deployment inefficiencies that create execution risk despite strong operational momentum.

Strengths

  • + Strong organic revenue growth of 23.2% YoY with consistent EPS growth of 23.4%, indicating sustainable demand in home healthcare sector
  • + Exceptional free cash flow generation at $50.7M (13.9% FCF margin) with minimal capex requirements ($1.7M), demonstrating capital-light business model and cash conversion efficiency
  • + Conservative balance sheet with low leverage (0.08x D/E), strong interest coverage (15.8x), and solid liquidity (1.83x current ratio) providing financial flexibility

Risks

  • ! Severely depressed return on equity (2.2%) and return on assets (1.7%) despite profitability, suggesting significant capital inefficiency or excess asset base requiring management resolution
  • ! Exposure to labor cost inflation, regulatory changes, and healthcare reimbursement rate pressures inherent to service sector and Medicare/Medicaid-dependent business
  • ! Significant margin compression from operating (9.4%) to net (6.9%) indicating material non-operating expenses that require clarification and monitoring

Key Metrics to Watch

Financial Metrics

Revenue
363.6M
Net Income
25.1M
EPS (Diluted)
$1.36
Free Cash Flow
50.7M
Total Assets
1.4B
Cash
103.1M

Profitability Ratios

Gross Margin 31.9%
Operating Margin 9.4%
Net Margin 6.9%
ROE 2.2%
ROA 1.7%
FCF Margin 13.9%

Balance Sheet & Liquidity

Current Ratio
1.83x
Quick Ratio
1.83x
Debt/Equity
0.08x
Debt/Assets
22.3%
Interest Coverage
15.84x
Long-term Debt
91.3M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-06T19:57:51.453183 | Data as of: 2026-03-31 | Powered by Claude AI